Should Radiotherapy after Primary Systemic Therapy be Administered with the Same Recommendations Made for Operable Breast Cancer Patients who Receive Surgery as first Treatment? A Critical Review
Restricted accessResearch articleFirst published online September, 2012
Should Radiotherapy after Primary Systemic Therapy be Administered with the Same Recommendations Made for Operable Breast Cancer Patients who Receive Surgery as first Treatment? A Critical Review
Primary systemic therapy is not only used in patients with locally advanced inoperable non-metastatic breast cancer but also for operable stage II and III cancer aimed at breast conservation. The indications for local-regional radiotherapy for patients who receive primary systemic therapy are still evolving. The purpose of this article is to provide a comprehensive discussion of how primary systemic therapy in operable breast cancer patients could affect the indications of radiotherapy to optimize local-regional treatment. An overview of available literature data regarding neoadjuvant treatment and radiotherapy is analyzed and discussed. Considering the variability of data on this issue, an appropriate approach could still be to tailor treatment decision to the individual clinical case.
HortobagyiG.N., BuzdarA.U., StromE.A., AmesF.C., SingletaryS.E.: Primary chemotherapy for early and advanced breast cancer.Cancer Lett, 90: 103–109, 1995.
2.
KuererH.M., HuntK.K., NewmanL.A., RossM.I., AmesF.C., SingletaryS.E.: Neoadjuvant chemotherapy in women with invasive breast carcinoma: conceptual basis and fundamental surgica issue.J Am Coll Surg, 190: 350–363, 2000.
3.
SmithI.E., JonesA.L., O'BrienM.E., McKinnaJ.A., SacksN., BaumM.: Primary medical (neo-adjuvant) chemotherapy for operable breast cancer.Eur J Cancer, 29A: 1796–1799, 1993.
4.
FisherB., BryantJ., WolmarkN., MamounasE., BrownA., FisherE.R., WickerhamD.L., BegovicM., DeCillisA., RobidouxA., MargoleseR.G., CruzA.B.Jr., HoehnJ.L., LeesA.W., DimitrovN.V., BearH.D.: Effect of preoperative CT on outcome of women with operable breast cancer.J Clin Oncol, 16: 2672–2685, 1998.
5.
VeronesiU., LuiniA., Del VecchioM., GrecoM., GalimbertiV., MersonM., RilkeF., SacchiniV., SaccozziR., SavioT., ZucaliR., ZurridaS., SalvadoriB.: Radiotherapy after breast-conserving surgery in women with localized cancer of the breast.N Engl J Med, 328: 1587–1591, 1993.
6.
ClarkR.M., WhelanT., LevineM., RobertsR., WillanA., McCullochP., LipaM., WilkinsonR.H., MahoneyL.J.: Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: An update.J Natl Cancer Inst, 88: 1659–1664, 1996.
7.
FisherB., AndersonS., BryantJ., MargoleseR.G., DeutschM., FisherE.R., JeongJ.H., WolmarkN.: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.N Engl J Med, 347: 1233–1241, 2002.
8.
LiljegrenG., HolmbergL., BerghJ., LindgrenA., TabárL., NordgrenH., AdamiH.O.: 10-year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: A randomized trial.J Clin Oncol, 17: 2326–2333, 1999.
9.
ClarkeM., CollinsR., DarbyS., DaviesC., ElphinstoneP., EvansE., GodwinJ., GrayR., HicksC., JamesS., MacKinnonE., McGaleP., McHughT., PetoR., TaylorC., WangY.: Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on locally recurrence and 15-year survival: an overview of randomised trials.Lancet, 366: 2087–2106, 2005.
10.
VeronesiU., CascinelliN., MarianiL., GrecoM., SaccozziR., LuiniA., AguilarM., MarubiniE.: Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer.N Engl J Med, 347: 1227–1232, 2002.
11.
van DongenJ.A., VoogdA.C., FentimanI.S., LegrandC., SylvesterR.J., TongD., van der SchuerenE., HelleP.A., van ZijlK., BartelinkH.: Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organisation for Research and Treatment of Cancer 10801 trial.J Natl Cancer Inst, 92: 1143–1150, 2000.
12.
FisherB., BrownA., MamounasE., WieandS., RobidouxA., MargoleseR.G., CruzA.B.Jr., FisherE.R., WickerhamD.L., WolmarkN., DeCillisA., HoehnJ.L., LeesA.W., DimitrovN.V.: Effect of preoperative CT in local-regional disease in women with operable breast cancer: findings from the National Surgical Adjuvant Breast and Bowel Project B-18.J Clin Oncol, 15: 2483–2493, 1997.
13.
WolmarkN., WangJ., MamounasE., BryantJ., FisherB.: Pre-operative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18.J Natl Cancer Inst Monogr, 30: 96–102, 2001.
14.
van der HageJ.A., van de VeldeC.J., JulienJ.P., Tubiana-HulinM., VanderveldenC., DuchateauL.: Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902.J Clin Oncol, 19: 4224–4237, 2001.
15.
KuskeR.R., FarrG.H.: Can preoperative chemotherapy cause patients with advanced breast cancer to become eligible for breast conserving therapy?Breast Cancer Res Treat, 23: 166, 1992.
16.
HuangE.H., StromE.A., PerkinsG.H., OhJ.L., ChenA.M., Meric-BernstamF., HuntK.K., SahinA.A., HortobagyiG.N., BuchholzT.A.: Comparison of risk of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score.Int J Radiat Oncol, 66: 352–357, 2006.
17.
SachelarieI., GrossbardM.L., ChadhaM., FeldmanS., GhesaniM., BlumR.H.: Primary systemic therapy of breast cancer.Oncologist, 11: 574–589, 2006.
18.
BearH.D., AndersonS., BrownA., SmithR., MamounasE.P., FisherB., MargoleseR., TheoretH., SoranA., WickerhamD.L., WolmarkN.: The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.J Clin Oncol, 21: 4165–4174, 2003.
19.
ColleoniM., NoleF., MinchellaI., NoberascoC., LuiniA., OrecchiaR., VeronesiP., ZurridaS., VialeG., GoldhirschA.: Pre-operative chemotherapy and radiotherapy in breast cancer.Eur J Cancer, 34: 641–645, 1998.
20.
GerlachB., AudretschW., GogolinF., KönigshausenT., RohnR., SchmittG., DimmerlingP., GrippS., HartmannK.A.: Remission rate in breast cancer treated with preoperative chemotherapy and radiotherapy.Stralenther Oncol, 179: 306–311, 2003.
21.
RingA., WebbA., AshleyS., AllumW.H., EbbsS., GuiG., SacksN.P., WalshG., SmithI.E.: Is surgery necessary after complete clinical remission following neoadjuvant chemotherapy for early breast cancer?J Clin Oncol, 21: 4540–4545, 2003.
22.
MauriD., PavlidisN., IoannidisJ.P.: Neoadjuvan versus adjuvant systemic treatment in breast cancer. A meta-analysis.J Natl Cancer Inst, 97: 188–194, 2005.
23.
Early Breast Cancer Trialists' Collaborative Group:Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overwiev of the randomised trials.Lancet, 355: 1757–1770, 2000.
24.
DaveauC., SavignoniA., Abrous-AnaneS., PiergaJ.Y., ReyalF., GautierC., KirovaY.M., DendaleR., CampanaF., FourquetA., BolletM.A.: Is radiotherapy an option for early breast cancer with complete clinical response after neoadjuvant chemotherapy?Int J Radiat Oncol Biol Phys, 79: 1452–1459, 2011.
25.
OvergaardM., HansenP.S., OvergaardJ., RoseC., AnderssonM., BachF., KjaerM., GadebergC.C., MouridsenH.T., JensenM.B., ZedelerK.: Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy: Danish Breast Cancer Cooperative Group 82b trial.New Engl J Med, 337: 949–955, 1997.
26.
RechtA., EdgeS.B., SolinL.J., RobinsonD.S., EstabrookA., FineR.E., FlemingG.F., FormentiS., HudisC., KirshnerJ.J., KrauseD.A., KuskeR.R., LangerA.S., SledgeG.W.Jr., WhelanT.J., PfisterD.G.: Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology.J Clin Oncol, 19: 1539–1569, 2001.
27.
RechtA., GrayR., DavidsonN.E., FowbleB.L., SolinL.J., CummingsF.J., FalksonG., FalksonH.C., TaylorSG4th, TormeyD.C.: Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of Eastern Cooperative Oncology Group.J Clin Oncol, 17: 1689–1700, 1999.
28.
BuchholzT.A., TuckerS.L., MasulloL., KuererH.M., ErwinJ., SalasJ., FryeD., StromE.A., McNeeseM.D., PerkinsG., KatzA., SingletaryS.E., HuntK.K., BuzdarA.U., HortobagyiG.N.: Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation.J Clin Oncol, 20: 17–23, 2002.
29.
SingletaryS.E., McNeeseM.D., HortobagyiG.N.Feasibility of breast-conservation surgery after induction chemotherapy for locally advanced breast cancer.Cancer, 69: 2849–2852, 1992.
30.
HuangE.H., TuckerS.L., StromE.A., McNeeseM.D., KuererH.M., BuzdarA.U., ValeroV., PerkinsG.H., SchechterN.R., HuntK.K., SahinA.A., HortobagyiG.N., BuchholzT.A.: Post-mastectomy radiation improves loco-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy.J Clin Oncol, 22: 4691–4699, 2004.
31.
HuangE.H., TuckerS.L., StromE.A., McNeeseM.D., KuererH.M., HortobagyiG.N., BuzdarA.U., ValeroV., PerkinsG.H., SchechterN.R., HuntK.K., SahinA.A., BuchholzT.A.: Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy.Int J Radiat Oncol Biol Phys, 62: 351–357, 2005.
32.
McGuireS.E., Gonzalez-AnguloA.M., HuangE.H., TuckerS.L., KauS.W., YuT.K., StromE.A., OhJ.L., WoodwardW.A., TereffeW., HuntK.K., KuererH.M., SahinA.A., HortobagyiG.N., BuchholzT.A.: Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy.Int J Radiat Oncol Biol Phys, 68: 1004–1009, 2007.
33.
NagarH., MittendorfE.A., StromE.A., PerkinsG.H., OhJ.L., TereffeW., WoodwardW.A., Gonzalez-AnguloA.M., HuntK.K., BuchholzT.A., YuT.K.: Local-regional recurrence with and without radiation therapy after neoadjuvant chemotherapy and mastectomy for clinically staged T3N0 breast cancer.Int J Radiat Oncol Biol Phys, 81: 782–787, 2011.
34.
GargA.K., OhJ.L., OswaldM.J., HuangE., StromE.A., PerkinsG.H., WoodwardW.A., YuT.K., TereffeW., Meric-BernstamF., HahnK., BuchholzT.A.: Effect of postmastectomy radiotherapy in patients <35 years old with stage II-III breast cancer treated with doxorubicin-based neoadjuvant chemotherapy and mastectomy.Int J Radiat Oncol Biol Phys, 69: 1478–1483, 2007.
35.
ChakravarthyB., PietenpolJ.A.: Combined modality management of breast cancer: development of predictive markers through proteomics.Semin Oncol, 30: 23–36, 2003.
36.
LenertJ.T., VlastosG., MirzaN.Q., WinchesterD.J., BinkleyS.M., AmesF.C., RossM.I., FeigB.W., HuntK.K., StromE., BuzdarA.U., HortobagyiG.N., SingletaryS.E.: Primary tumor response to induction chemotherapy as a predictor of histological status of axillary nodes in operable breast cancer patients.Ann Surg Oncol, 6: 762–767, 1999.
37.
WoodwardW.A., Vinh-HungV., UenoN.T., ChengY.C., RoyceM., TaiP., VlastosG., WallaceA.M., HortobagyiG.N., NietoY.: Prognostic value of nodal ratios in node-positive breast cancer.J Clin Oncol, 24: 2910–2916, 2006.
38.
TruongP.T., WoodwardW.A., ThamesH.D., RagazJ., OlivottoI.A., BuchholzT.A.: The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1–3 positive nodes: an analysis of prospective data from British Columbia and the M.D. Anderson Cancer Center.Int J Radiat Oncol Biol Phys, 68: 59–65, 2007.
39.
DaveauC., StevensD., BrainE., BergesO., VilletteS., MoissonP., GardnerM., De la LandeB., LasryS., LabibA., Le ScodanR.: Is regional lymph node irradiation necessary in stage II to III breast cancer patients with negative pathologic node status after neoadjuvant chemotherapy?Int J Radiat Oncol Biol Phys, 78: 337–342, 2010.
40.
ShaharK.H., HuntK.K., ThamesH.D., RossM.I., PerkinsG.H., KuererH.M., StromE.A., McNeeseM.D., MericF., SchechterN.R., SahinA.A., MiddletonL.P., BuchholzT.A.: Factors predictive of having four or more positive axillary lymph nodes in patients with positive sentinel lymph nodes: implications for selection of radiation fields.Int J Radiat Oncol Biol Phys, 59: 1074–1079, 2004.
ClouthB., ChandrasekharanS., InwangR., SmithS., DavidsonN., SauvenP.: The surgical management of patients who achieve a complete pathological response after primary chemotherapy for locally advanced breast cancer.Eur J Surg Oncol, 33: 961–966, 2007.
43.
KaufmannM., HortobagyiG.N., GoldhirschA., SchollS., MakrisA., ValagussaP., BlohmerJ.U., EiermannW., JackeszR., JonatW., LebeauA., LoiblS., MillerW., SeeberS., SemiglazovV., SmithR., SouchonR., StearnsV., UntchM., von MinckwitzG.: Recommendations from an international expert panel on the use of neoadjuvant systemic treatment of operable breast cancer: an update.J Clin Oncol, 24: 1940–1949, 2006.
44.
NadeemR., ChaglaL.S., HarrisO., DesmondS., ThindR., FlavinA., AudisioR.A.: Tumor localization with a metal coil before the administration of neo-adjuvant chemotherapy.Breast, 14: 403–407, 2005.
45.
KaufmannM., von MinckwitzG., MamounasE.P., CameronD., CareyL.A., CristofanilliM., DenkertC., EiermannW., GnantM., HarrisJ.R., KarnT., LiedtkeC., MauriD., RouzierR., RuckhaeberleE., SemiglazovV., SymmansW.F., TuttA., PusztaiL.: Recommendations from an International Consensus Conference on the Current Status and Future of Neoadjuvant Systemic Therapy in Primary Breast Cancer.Ann Surg Oncol, 19: 1508–1516, 2012.
46.
BuchholzT.A., LehmanC.D., HarrisJ.R., PockajB.A., KhouriN., HyltonN.F., MillerM.J., WhelanT., PierceL.J., EssermanL.J., NewmanL.A., SmithB.L., BearH.D., MamounasE.P.: Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference.J Clin Oncol, 26: 791–797, 2008.
47.
But-HadzicJ., Bilban-JakopinC., HadzicV.: The role of radiation therapy in locally advanced breast cancer.Breast J, 16: 183–188, 2010.
